Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

686 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HPV16/18 Antibody Responses After a Single Dose of Nonavalent HPV Vaccine.
Zeng Y, Moscicki AB, Woo H, Hsu CH, Kemp TJ, Pinto LA, Szabo E, Dimond E, Bauman J, Sahasrabuddhe VV, Chow HS. Zeng Y, et al. Among authors: bauman j. Pediatrics. 2023 Jul 1;152(1):e2022060301. doi: 10.1542/peds.2022-060301. Pediatrics. 2023. PMID: 37317810 Free PMC article. Clinical Trial.
A Phase 2, Double-blind, Randomized Controlled Trial of PROSTVAC in Prostate Cancer Patients on Active Surveillance.
Parsons JK, Pinto PA, Pavlovich CP, Uchio E, Nguyen MN, Kim HL, Gulley JL, Sater HA, Jamieson C, Hsu CH, Wojtowicz M, House M, Schlom J, Donahue RN, Dahut WL, Madan RA, Bailey S, Centuori S, Bauman JE, Parnes HL, Chow HS. Parsons JK, et al. Among authors: bauman je. Eur Urol Focus. 2023 May;9(3):447-454. doi: 10.1016/j.euf.2022.12.002. Epub 2022 Dec 12. Eur Urol Focus. 2023. PMID: 36517408 Free PMC article. Clinical Trial.
Author Correction: Head and neck squamous cell carcinoma.
Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Johnson DE, et al. Nat Rev Dis Primers. 2023 Jan 19;9(1):4. doi: 10.1038/s41572-023-00418-5. Nat Rev Dis Primers. 2023. PMID: 36658129 No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 37785313
Palliative Care and End-of-Life Care in Metastatic Pancreatic Cancer.
O'Brien J, Halsey B, Connors M, Deng M, Handorf E, Berardi G, Lynch S, Sorice K, Reddy S, Meyer J, Bauman J, Dotan E. O'Brien J, et al. Among authors: bauman j. J Palliat Med. 2024 Dec 5. doi: 10.1089/jpm.2024.0313. Online ahead of print. J Palliat Med. 2024. PMID: 39636708
End-of-Life Care in Hematology/Oncology Fellowship.
Albert MJ, Liu Y, Varshavsky A, Egleston BL, Dotan E, McShane MM, Edelman MJ, Collins ME, Bauman JR. Albert MJ, et al. Among authors: bauman jr. J Palliat Med. 2024 Nov 27. doi: 10.1089/jpm.2024.0198. Online ahead of print. J Palliat Med. 2024. PMID: 39602169
Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trial.
Mell LK, Torres-Saavedra PA, Wong SJ, Kish JA, Chang SS, Jordan RC, Liu T, Truong MT, Winquist EW, Takiar V, Wise-Draper T, Robbins JR, Rodriguez CP, Awan MJ, Beadle BM, Henson C, Narayan S, Spencer SA, Powell S, Dunlap N, Sacco AG, Hu KS, Park HS, Bauman JE, Harris J, Yom SS, Le QT. Mell LK, et al. Among authors: bauman je. Lancet Oncol. 2024 Dec;25(12):1576-1588. doi: 10.1016/S1470-2045(24)00507-2. Epub 2024 Nov 14. Lancet Oncol. 2024. PMID: 39551064 Free article. Clinical Trial.
Corrigendum to "Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK -positive advanced non-small cell lung cancer" [Lung Cancer 195 (2024) 107919].
Bauman JR, Liu G, Preeshagul I, Liu SV, Melosky B, Abrahami D, Li B, Thomaidou D, Duncan K, Krulewicz S, Rupp M, Lin JJ. Bauman JR, et al. Lung Cancer. 2024 Nov;197:108000. doi: 10.1016/j.lungcan.2024.108000. Epub 2024 Nov 2. Lung Cancer. 2024. PMID: 39488462 Free article. No abstract available.
686 results